Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

COX-2 in cancer--a player that's defining the rules.

Hawk ET, Viner JL, Dannenberg A, DuBois RN.

J Natl Cancer Inst. 2002 Apr 17;94(8):545-6. No abstract available.

2.

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.

Dannenberg AJ, Subbaramaiah K.

Cancer Cell. 2003 Dec;4(6):431-6. Review. No abstract available.

3.

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.

Song X, Lin HP, Johnson AJ, Tseng PH, Yang YT, Kulp SK, Chen CS.

J Natl Cancer Inst. 2002 Apr 17;94(8):585-91.

4.

Selective COX-2 inhibitors as chemopreventive and therapeutic agents.

Grossman HB.

Drugs Today (Barc). 2003 Mar;39(3):203-12. Review.

PMID:
12730704
5.

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.

Biochem Pharmacol. 2004 Apr 15;67(8):1469-78.

PMID:
15041464
6.
7.
8.

COX-2 inhibitors in oncology.

Haller DG.

Semin Oncol. 2003 Aug;30(4 Suppl 12):2-8. Review. No abstract available.

PMID:
14508721
9.

[Therapeutic advances with coxibs: few certainties and a lot of doubts].

Jouzeau JY, Daouphars M, Netter P.

Therapie. 2004 Mar-Apr;59(2):207-11. Review. French. No abstract available.

PMID:
15359614
10.

Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.

Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.

Cancer Res. 2002 Nov 15;62(22):6706-11.

11.
12.

Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma.

Wun T, McKnight H, Tuscano JM.

Leuk Res. 2004 Feb;28(2):179-90.

PMID:
14654083
13.
15.

Mechanism of inhibition of novel COX-2 inhibitors.

Gierse J, Kurumbail R, Walker M, Hood B, Monahan J, Pawlitz J, Stegeman R, Stevens A, Kiefer J, Koboldt C, Moreland K, Rowlinson S, Marnett L, Pierce J, Carter J, Talley J, Isakson P, Seibert K.

Adv Exp Med Biol. 2002;507:365-9. No abstract available.

PMID:
12664611
16.

Pharmacology and clinical action of COX-2 selective NSAIDs.

Bovill JG.

Adv Exp Med Biol. 2003;523:201-14. Review. No abstract available.

PMID:
15088852
17.

[Cyclooxygenases in the spinal cord and the relationship with pain].

Li SQ, Li WB.

Sheng Li Ke Xue Jin Zhan. 2003 Oct;34(4):359-60. Review. Chinese. No abstract available.

PMID:
14992024
18.
19.

Cyclooxygenase-2 inhibitors in cancer prevention and treatment.

Masferrer JL.

Adv Exp Med Biol. 2003;532:209-13. Review. No abstract available.

PMID:
12908559
20.

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.

Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM.

Cancer Res. 2004 Sep 15;64(18):6549-55.

Items per page

Supplemental Content

Write to the Help Desk